Evidence map›Paper›PMID 31649809›Full record

ArticleMolecular autism2019

Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.

Hyung-Goo Kim, Jill A Rosenfeld, Daryl A Scott, Gerard Bénédicte, Jonathan D Labonne, Jason Brown, Marianne McGuire, Sonal Mahida, Sakkubai Naidu, Jacqueline Gutierrez and 18 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular autism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Genetic alterations in SUPT6H are associated with neurodevelopmental disorders.Biochimica et biophysica acta. Molecular basis of disease · 2026
    Article
  3. Article
  4. Article
  5. Dissecting Gene Regulatory Networks Governing Human Cortical Cell Fate.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Review
  8. Asynchronous microexon splicing ofbioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. International journal of molecular sciences · 2022
    Article
  17. Article
  18. Novel Pathogenic Variant (c.1171A>T) inMolecular syndromology · 2022
    Article
  19. Review
  20. Disease Modeling of Rare Neurological Disorders in Zebrafish.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 16 institutions in 5 countries.

Hyung-Goo Kim1Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.ORCID 0000-0003-4497-4686
Jill A Rosenfeld2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA.
Daryl A Scott2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA.
Gerard Bénédicte4Laboratoires de Diagnostic Génétique, Unité de génétique moléculaire, Nouvel Hôpital Civil, Strasbourg Cedex, France.
Jonathan D Labonne5Section of Reproductive Endocrinology, Infertility & Genetics, Department of Obstetrics & Gynecology, Augusta University, Augusta, GA USA.
Jason Brown5Section of Reproductive Endocrinology, Infertility & Genetics, Department of Obstetrics & Gynecology, Augusta University, Augusta, GA USA.
Marianne McGuireBaylor Genetic Laboratories, Houston, TX USA.
Sonal Mahida7Kennedy Krieger Institute, Baltimore, MD USA.
Sakkubai Naidu7Kennedy Krieger Institute, Baltimore, MD USA.
Jacqueline Gutierrez3Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX USA.
Gaetan Lesca8Department of Medical Genetics, Lyon University Hospital, Lyon, France.
Vincent des Portes9Department of Pediatric Neurology, Lyon University Hospital, Lyon, France.
Ange-Line Bruel10Équipe Génétique des Anomalies du Développement (GAD), INSERM, Dijon, France.
Arthur SorlinCentre de Génétique, CHU Dijon Bourgogne, Dijon, France.
Fan Xia2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA.
Yline CapriService de Génétique Clinique, CHU Robert Debré, Paris, France.
Eric Muller13Clinical Genetics, Stanford Children's Health at CPMC, San Francisco, CA USA.
Dianalee McKnight14GeneDx, Gaithersburg, MD USA.
Erin Torti14GeneDx, Gaithersburg, MD USA.
Franz Rüschendorf15Max Delbrück Center (MDC) for Molecular Medicine, Berlin, Germany.
Oliver Hummel15Max Delbrück Center (MDC) for Molecular Medicine, Berlin, Germany.
Zeyaul Islam16Diabetes Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University, Doha, Qatar.
Prasanna R Kolatkar16Diabetes Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University, Doha, Qatar.
Lawrence C Layman5Section of Reproductive Endocrinology, Infertility & Genetics, Department of Obstetrics & Gynecology, Augusta University, Augusta, GA USA.
Duchwan Ryu18Department of Statistics and Actuarial Science, Northern Illinois University, DeKalb, IL USA.
Il-Keun Kong19Department of Animal Science, Division of Applied Life Science (BK21plus), Gyeongsang National University, Jinju, Korea.
Suneeta Madan-Khetarpal20Pediatric Medical Genetics, Children's Hospital of Pittsburgh, Pittsburgh, PA USA.
Cheol-Hee Kim21Department of Biology, Chungnam National University, Daejeon, Korea.
Baylor College of Medicine · USAugusta University · USHamad bin Khalifa University · QAKennedy Krieger Institute · USLentigen Technology (United States) · USLyon College · USMax Delbrück Center · DEBaylor Genetics · USChildren's Hospital of Pittsburgh · USCHU Dijon Bourgogne · FRChungnam National University · KRGyeongsang National University · KRHôpital Civil, Strasbourg · FRInserm · FRNorthern Illinois University · USStanford Health Care · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Diagnostic trio whole exome sequencing, Sanger sequencing, use of GeneMatcher, targeted gene panel sequencing, and MiSeq sequencing techniques were used to identify and confirm variants. RT-qPCR was used to measure the normal expression pattern of Results: We have identified seven heterozygous coding mutations, among which six are de novo (not maternal in one). Mutations include four frameshifts, one nonsense mutation in two patients, and one heterozygous missense mutation in the AT Hook domain, predicted to be deleterious and likely to cause loss of PHF21A function. We also found a new C-terminal domain composed of an intrinsically disordered region. This domain is truncated in six patients and thus likely to play an important role in the function of PHF21A, suggesting that haploinsufficiency is the likely underlying mechanism in the phenotype of seven patients. Our results extend the phenotypic spectrum of Conclusion: Deleterious nonsense, frameshift, and missense mutations disrupting the AT Hook domain and/or an intrinsically disordered region in PHF21A were found to be associated with autism spectrum disorder, epilepsy, hypotonia, neurobehavioral problems, tapering fingers, clinodactyly, and syndactyly, in addition to intellectual disability and craniofacial anomalies. This suggests that

Indexed as

BehaviorAdolescentAmino Acid SequenceAutistic DisorderBrainChildChild, PreschoolCraniofacial AbnormalitiesEpilepsyFemaleHistone DeacetylasesHumansInfantInfant, NewbornIntellectual DisabilityMaleHistone DeacetylasesPHF21A protein, humanRNA, MessengerAT Hook domainAutism spectrum disorder (ASD)BHC80Intellectual disability (ID)Intrinsically disordered region (IDR)KDM1ANeurodevelopmental disordersPHF21APotocki-Shaffer syndrome (PSS)

Identifiers

PMID31649809
PMCPMC6805429
OpenAlexW2981366470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.